Technical Analysis for BIAF - bioAffinity Technologies, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | N/A | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
1,2,3 Pullback Bullish | Bullish Swing Setup | 0.00% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
NR7 | Range Contraction | 0.00% | |
NR7-2 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
Calm After Storm | Range Contraction | 0.84% | |
NR7 | Range Contraction | 0.84% | |
Narrow Range Bar | Range Contraction | 0.84% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Gap Up Closed | about 7 hours ago |
Gap Up Partially Closed | about 7 hours ago |
Gapped Up (Partial) | about 7 hours ago |
Up 3% | about 7 hours ago |
Up 2% | about 7 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/01/2023
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Cancer Life Sciences Biology Diagnostic Tests Molecular Diagnostics Lung Cancer Cancer Therapeutics
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Cancer Life Sciences Biology Diagnostic Tests Molecular Diagnostics Lung Cancer Cancer Therapeutics
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 15.55 |
52 Week Low | 1.31 |
Average Volume | 1,612,482 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 2.15 |
20-Day Moving Average | 2.17 |
10-Day Moving Average | 2.67 |
Average True Range | 0.37 |
RSI | 54.13 |
ADX | 41.77 |
+DI | 37.28 |
-DI | 11.21 |
Chandelier Exit (Long, 3 ATRs) | 2.87 |
Chandelier Exit (Short, 3 ATRs) | 2.60 |
Upper Bollinger Bands | 3.22 |
Lower Bollinger Band | 1.12 |
Percent B (%b) | 0.61 |
BandWidth | 96.80 |
MACD Line | 0.17 |
MACD Signal Line | 0.13 |
MACD Histogram | 0.0363 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.60 | ||||
Resistance 3 (R3) | 2.60 | 2.55 | 2.56 | ||
Resistance 2 (R2) | 2.55 | 2.50 | 2.54 | 2.55 | |
Resistance 1 (R1) | 2.47 | 2.47 | 2.45 | 2.47 | 2.54 |
Pivot Point | 2.42 | 2.42 | 2.40 | 2.41 | 2.42 |
Support 1 (S1) | 2.34 | 2.37 | 2.32 | 2.34 | 2.26 |
Support 2 (S2) | 2.29 | 2.34 | 2.28 | 2.25 | |
Support 3 (S3) | 2.21 | 2.29 | 2.24 | ||
Support 4 (S4) | 2.21 |